You have probably seen the letters on a treatment menu or scrolling through your feed: PRP, PRF, PRFM, PDRN, exosomes. They travel with words like regenerative, growth factors, and your body's own healing. Some of them use your own blood. One is marketed as coming from salmon. It sounds like the future of skin, and it also sounds a little like alphabet soup.
If it is hard to tell what is real, you are in good company. These are several different things, doing different jobs, backed by very different amounts of evidence, and standing in very different places with the Food and Drug Administration. That last part matters more than the branding, and it is what a good physician walks you through before anything is drawn into a syringe.
Here is one fact worth knowing up front, because it shapes how these should be offered rather than whether: according to the FDA, there are currently no FDA-approved exosome products. That does not put them off-limits. It makes physician guidance and honest disclosure the whole ballgame, a thread we will keep pulling as we go.
PRP: it starts with your own blood
PRP stands for platelet-rich plasma, and the name is literal. A clinician draws a small amount of your blood, places it in a machine that spins it fast enough to separate out the platelets, and reinjects that concentrated portion into your scalp or skin. The American Academy of Dermatology describes it as a straightforward three-step procedure. Because PRP is made from your own blood rather than a manufactured product, it is not a foreign substance introduced into your body.
Platelets carry growth factors, the signaling proteins your body already uses to repair itself, which is the theory behind using them for thinning hair and aging skin. What surprises most people is how thin the proof still is. The Academy is candid that few large studies exist, in part because the FDA does not require the kind of big, expensive trials for PRP that it demands of new drugs, so there is, in its words, little evidence to show that it works or that it does not.
It helps to separate two ideas that sound identical. The device that spins your blood can be FDA-cleared, and several are, but that clearance is not the same as the FDA approving PRP as a proven treatment for your face. Most of these uses remain off-label.
PRF and PRFM: the same idea, prepared differently
PRF, platelet-rich fibrin, is best understood as a close relative of PRP rather than a separate invention. It comes from the same place, your own blood, with the difference lying in the processing rather than the source, a newer generation of the platelet idea. A further step in the same family is PRFM, platelet-rich fibrin matrix, which prepares your platelets into a slower-releasing scaffold. All of it starts with your own biology.
Because they are variations on that same approach, PRF and PRFM sit in the same evidence neighborhood as PRP. They are prepared from you rather than manufactured, and like PRP they are largely used off-label rather than as an FDA-approved therapy. We offer PRF and PRFM at OmriMed, and we describe them the honest way: reasonable options built from your own blood, with the research still catching up to the enthusiasm.
Not everything that rebuilds collagen arrives in a syringe. If stimulating your own collagen without an injection appeals to you, energy-based options take a different route to a similar goal, which our explainer on how Sofwave uses ultrasound to prompt your own collagen walks through.
Exosomes: real promise, honest limits
Exosomes are tiny packets that cells release to signal other cells, and in aesthetics they are used to carry regenerative messages into your skin. The science is genuinely interesting, and it is also genuinely early, which is why the way exosomes are offered matters more than the word itself. As noted above, the FDA states plainly that there are currently no FDA-approved exosome products.
That is not a detail to gloss over. In December 2019 the agency issued a public safety notification after several patients in Nebraska suffered serious adverse events tied to unapproved products marketed as containing exosomes. The FDA is direct that exosomes intended to treat conditions in people are regulated as drugs and biological products, which means they require agency review, and that some clinics make claims the evidence does not support.
None of that means exosomes have no place. It means they belong with a physician who will tell you exactly where they stand. We offer exosome treatments at OmriMed, and if they come up in your plan you will hear it plainly: they are not FDA-approved, the evidence is still developing, and the decision is yours to make with the full picture in front of you. The FDA's own suggested questions, whether the agency has reviewed a product and what its investigational new drug number is, are ones we welcome rather than deflect. The difference between a responsible exosome offering and a reckless one is not the vial. It is whether the person offering it will be straight with you about it.
PDRN, and the questions that sort hype from help
PDRN, short for polydeoxyribonucleotide, is another name you may hear, marketed as being made from salmon DNA. Whatever the origin story, the point for you is not the source material. It is the same short list of questions.
The FDA publishes plain guidance for anyone weighing a regenerative product: ask whether the FDA has reviewed it, understand that products meant to treat a condition generally require approval, and report any harm to the agency's MedWatch program. Those questions are not meant to make you distrust your clinician. They are meant to give you a shared, factual footing, and a good clinician will already be answering them before you ask.
That is the throughline for all of these. Regenerative is a spectrum, not a seal of quality. Some of it is drawn from your own body with a modest but honest evidence base. Some of it, like exosomes, carries real promise while still sitting outside FDA approval. The letters on the menu do not tell you where a given option stands. The evidence does, and so does a physician who will say it plainly and who favors natural-looking results built on clinical restraint over whatever is trending.
What this means for you in Lubbock
Picture a Lubbock teacher in her fifties who has noticed her hair thinning at the part and read that PRP might help. Nothing here should scare her away from asking. PRP is drawn from her own blood rather than a manufactured product, and for the right person it can be reasonable to try, as long as she understands that the science is still modest and no result is promised.
The same honesty applies if exosomes or PRFM come into the conversation. We offer them, and we will also tell her plainly that exosomes are not FDA-approved and that the evidence is still early, so she can decide with the full picture rather than on the strength of an advanced-sounding name. The goal is not to say yes or no to regenerative aesthetics as a whole. It is to match the treatment to the evidence, and to make sure the person recommending it can explain where each option actually stands. That philosophy, looking like a rested version of yourself rather than an altered one, is the kind of unhurried conversation I would rather have with you than rush past on the way to a sale.
Curious where a treatment really stands? Let's talk it through
If you have wondered whether PRP, PRF, PRFM, exosomes, or anything labeled regenerative belongs in your own plan, we would rather sort it out with you than sell it to you. We offer these options at Omri Med in Lubbock, and we start with an unhurried conversation about your goals and what the evidence actually supports. Reach us through our contact page or by phone at (806) 778-4395, and we will help you tell what is proven apart from what is merely popular.
Sources
- No FDA-approved exosome products, the serious adverse events reported in patients in Nebraska, the regulation of exosomes as drugs and biological products, and the advice to ask whether the FDA reviewed the product and to request its investigational new drug number: U.S. Food and Drug Administration, Public Safety Notification on Exosome Products, 6 December 2019
- "There are currently no FDA-approved exosome products," and guidance to report problems to the FDA's MedWatch program: U.S. Food and Drug Administration, Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes
- PRP as a three-step procedure using the patient's own blood, few studies because the FDA does not require large drug-style trials, and little evidence to show that it works or does not: American Academy of Dermatology, "Is platelet-rich plasma the secret to younger-looking skin?"
- A cleared device that prepares platelet-rich plasma from a small sample of the patient's blood: U.S. Food and Drug Administration, 510(k) device information, Platelet and Plasma Separator (BK241083)
- PRP obtained from autologous blood by single- or double-spin centrifugation, with PRP and cell-based biologic treatments remaining investigational or off-label: Patel NC, Das JM, Aijaz T. "Regenerative Therapy in Pain." StatPearls, NCBI Bookshelf, 2026
This article is for general educational purposes and is not medical advice, diagnosis, or treatment, and it does not create a physician-patient relationship. Individual results vary, and no outcome is guaranteed. Treatment decisions should be made with a qualified physician who knows your full medical history. Omri Med is a private-pay concierge practice; membership is limited and does not replace health insurance.